← Leaderboards
Jean-Nicolas Gallant
Vanderbilt University
$116,806
Attributed
$116,806
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44.5K · FY2016–18$50K$37.5K$25K$12.5K$0
'16
'17
'18
Funding mix
By agency
NIH$116,806 · 1
By mechanism
F30$116,806 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Scott Hiebert$33,340,607
- Eugene M. Oltz$20,457,685
- Neil Osheroff$12,336,075
- Pierre P Massion$18,568,000
- Christine M. Lovly$3,238,974
Others in their field
Top investigators on “Anchorage-Independent Growth”
- Max Costa · New York University School Of Medicine$6,513,886
- Alan P Fields · University Of Texas Medical Br Galveston$6,383,278
- Daniel J Lew · Duke University$4,964,433
- Channing J Der · University Of North Carolina Chapel Hill$4,682,390
- Rakesh Kumar · University Of Texas Md Anderson Can Ctr$4,584,420
- David A Cheresh · Scripps Research Institute$4,563,004
Research focus
Anchorage-Independent GrowthAtp PhosphohydrolaseBaseBiologyCancer EtiologyCancer PatientCancer TypeCareerCell LineCellsCessation Of LifeCharacteristicsChromosomal TranslocationClinicClinical DataCollaborationsC-TerminalData SetDna BindingDna Sequence AlterationEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEthylnitrosoureaExons
Grant awards (3)
EGFR rearrangements as oncogenic drivers and therapeutic targets in lung cancer$44,524
F30 · FY2018 · CA · contact PI
EGFR rearrangements as oncogenic drivers and therapeutic targets in lung cancer$44,044
F30 · FY2017 · CA · contact PI
EGFR rearrangements as oncogenic drivers and therapeutic targets in lung cancer$28,238
F30 · FY2016 · CA · contact PI